PROTAC® Degraders & Targeted Protein Degradation

Targeted Protein Degradation (TPD) refers to the use of heterobifunctional small molecule "degraders" (e.g. PROTAC molecules) to achieve knockdown of target proteins within cells. PROTACs, also known as Active Degraders, consist of binding moieties for an E3 ubiquitin ligase and a target protein joined by a linker. The binding of both moieties results in the formation of a ternary complex between target protein and E3 ligase, leading to polyubiquitination of the target protein, its recognition by the proteasome and subsequent degradation.

Targets
Literature (4)

Bio-Techne's Complete Solution for PROTACs & Targeted Protein Degradation

The Bio-Techne family of brands offers a complete solution for Targeted Protein Degradation research and development. Click the image below to find out more about our Active Degraders (PROTACs), TAG Degradation Platform (aTAG, dTAG), Degrader Building Blocks, Ubiquitin Proteasome System Proteins and Assays, Assays for Protein Degradation and Custom Degrader Services, including our new, easy to use PROTAC Panel Builder.


Resources for PROTACs & Targeted Protein Degradation

Virtual Symposium: Advances inTargeted Protein Degradation

This virtual symposium brings together leading experts in the field of Targeted Protein Degradation to present their research and provide insights on the field. The symposium covers innovative new research tools and techniques that are helping to advance the field. Organized by Bio-Techne and live streamed on 14th July 2021, this symposium is now available to stream on demand.

Stream on Demand!
Targeted Protein Degradation Virtual Symposium

Blog Post: Development of a KRAS-Targeting PROTAC

In this question-and-answer session, our Senior Product Specialist, Alex Moloney PhD, talks to Michael Bond (Yale University) about the development of a KRAS-G12C-targeting PROTAC®, LC 2, which is now available from Tocris.

Read Now!
LC 2 - First Endogenous KRAS-G12C Degrader

Whitepaper: Validating Targets for Targeted Protein Degradation Using dTAG

Our whitepaper describes a comprehensive workflow solution for target validation using the TAG Degradation Platform. The whitepaper provides guidance on TAG knock-in cell-line generation, the use of dTAG Degraders to knockdown your POI, and Simple Western™ instruments and antibodies validated for western blotting to measure target knockdown.

Request Whitepaper
dTAG Whitepaper

Paper: Reviewing the Toolbox for Degrader Development in Oncology

This review written by our in-house experts and published in Current Opinion in Pharmacology discusses the guidelines, reagents, and technologies available to support Degrader research and development in oncology.

Read Paper
Current Opinion in Pharmacology Review Paper

Webinar: Tackling Targeted Protein Degradation - Workflow Solutions for PROTAC® Degrader Development Programs

This webinar outlines the comprehensive workflow solution available from Bio-Techne for Degrader development programs, from target validation and design of small molecule degraders to proteins and assays for profiling candidate degraders. Presented by our Innovation Manager, Hannah Maple, PhD, the webinar was originally given as a tech talk at Cell Bio Virtual 2020.

Watch Now!
Webinar: Tackling Targeted Protein Degradation

PROTAC Panel Builder

With our new PROTAC Panel Builder you can quickly and easily request a quote for a selected panel of E3 ligase ligands plus linkers for your Degrader discovery project.

View Panel Builder Tool
PROTAC Panel Builder Tool

A Short Animation Explaining Degrader Technology

Our short animation explains the fundamentals of Targeted Protein Degradation (TPD) using small molecule Degraders or PROTACs. Degraders are heterobifunctional compounds that harness the ubiquitin/proteasome system to selectively remove proteins from cells.

Watch Now!
What is Targeted Protein Degradation?

What is dTAG?

Our short animation explains the dTAG system, which provides an alternative to genetic methods of target validation. dTAG harnesses the ubiquitin/proteasome system to selectively degrade fusion proteins comprising mutant FKBP12 and a target protein of interest.

Watch Now!
What is dTAG?

Webinar: New Frontiers in Targeted Protein Degradation and Degrader Development

This webinar provides an introduction to the field of Targeted Protein Degradation, discussing design and optimization of Degrader, or PROTAC, molecules and how structural biology and rational design can shed light on the Degrader development process. The second section of the webinar presents the dTAG platform for target validation.

Watch Now!
New Frontiers in TPD and Degrader Development

Blog Post: dTAG - A Protein Degradation Platform for Target Validation

Read our blog post to find out more about dTAG Degraders and their potential for use in the validation of targets for which there is no know ligand.

Read Now!
What is dTAG?

Research Paper: Developing Degraders

Tocris scientists have established a set of guidelines relating to the physicochemical properties required in the design and synthesis of cell-permeable Degrader/ PROTAC molecules. Read the paper in MedChemComm to find out more.

Read Now!
Principles of Degrader Design


PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Literature for PROTAC® Degraders & Targeted Protein Degradation

Tocris offers the following scientific literature for PROTAC® Degraders & Targeted Protein Degradation to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Targeted Protein Degradation

Targeted Protein Degradation Research Product Guide

This brochure highlights the tools and services available from Bio-Techne to support Targeted Protein Degradation research, including:

  • Active Degraders
  • TAG Degradation Platform
  • Degrader Building Blocks
  • Custom Degrader Services
  • Ubiquitin-Proteasome System Proteins and Assays
  • Assays for Protein Degradation
Developing Degraders

Developing Degraders Poster

This poster describes the generation of a database of Degraders (PROTACs®) from the literature. The Degraders were profiled according to the constituent ligands, linker type, linker length and physicochemical properties and this information was used to establish a set of guidelines for the design and synthesis of cell-permeable Degrader molecules. Presented at the 20th SCI/RSC Medicinal Chemistry Symposium 2019, Cambridge, UK.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Enabling Research By Provision of Chemical Tools

Enabling Research By Provision of Chemical Tools Poster

The Tocris chemistry team has considerable chemistry knowledge and skill which it has recently been applying to the generation of new chemical probes from known tools and compounds to help answer biological questions. This poster presents some of the work carried out by Tocris scientists and focuses on two areas: the generation of libraries of chemical building blocks to support Degrader (PROTAC) research and the development of a fluorescent probe to study integrin biology. Presented at Chemical Tools for Complex Biological Systems II, 2019, Janelia Research Campus, USA.
Targeted Protein Degradation

Targeted Protein Degradation Poster

Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia